Block Listing Update

RNS Number : 6583W

Futura Medical PLC

11 November 2014

 



For immediate release

11 November 2014

Futura Medical plc

("Futura" or "the Company")

Block Listing Update

Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology announces that, since the last update in April 2014, there have been no changes to the numbers of shares block listed in respect of the Company's two option plans.

The table below provides further detail.

Name of company:	Futura Medical plc
Name of scheme:	Unapproved Share Option Scheme ("USOS") EMI Share Option  Scheme ("EMI")
Period of return:	From:             28 April 2014 To:                   10 November 2014
Number and class of securities not issued under the scheme(s)	USOS:             1,786,435 ordinary shares of 0.2p EMI:                 1,828,306 ordinary shares of 0.2p Total:               3,614,741
Number of securities issued under the scheme(s) during the period	USOS:             Nil EMI:                 Nil
Balance under the scheme(s) of securities not yet issued at the end of the period	USOS:             1,786,435 EMI:                 1,828,306 Total:               3,614,741
Number and class of securities originally admitted and the date of admission	USOS:                814,424 on 25 May 2011 and                         1,193,959 on 8 October 2013 Total:               2,008,383 Total EMI:                 1,520,576 on 25 May 2011 and                         1,476,041 on 8 October 2013 Total:               2,996,617 Total Total:               5,005,000
Name of contact:	Derek Martin, Chief Financial Officer
Telephone number of contact:	[phone]

For any further information please contact:

Futura Medical plc
James Barder, Chief Executive	Tel: [phone]
mail to: [e-mail]	www.futuramedical.com
Nominated Adviser:
N+1 Singer Aubrey Powell	Tel:[phone]
For media enquiries please contact:
Buchanan
Mark Court / Sophie Cowles	Tel: [phone]

Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com

 

END

 

 

BLRGGGCAGUPCPUU